logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
5/18/2018 8:01:27 AM Ligand Prices Offering Of $650 Mln Of 0.75% Convertible Senior Notes Due 2023 In A Private Offering
5/8/2018 4:02:14 PM Ligand Pharma Q1 Adj. EPS $1.55 Vs $0.57 Last Year
3/30/2018 9:16:40 AM Ligand Reaches Agreement With VenBio To Make Worldwide OmniAb Platform License Accessible To Portfolio Companies
3/6/2018 4:04:00 PM Ligand Licenses Glucagon Receptor Antagonist Program To Roivant Sciences
2/21/2018 4:03:17 PM Ligand Pharma Q4 Loss/share $0.33 Vs. Loss $0.15 Year Ago
1/22/2018 9:01:49 AM Ligand Enters Into Worldwide OmniAb Platform License Agreement With Ferring Pharma
1/11/2018 9:02:50 AM Ligand Enters Worldwide OmniAb Platform License Agreement With Glenmark Pharmaceuticals
1/3/2018 9:05:49 AM Ligand Says Now Expects FY17 Total Revenue Of About $140 Mln, Adj. EPS Of $3.13-$3.16
11/9/2017 4:04:19 PM Ligand Pharmaceuticals Q3 EPS $0.36 Vs. $0.05 Year Ago